Pharmacyclics
is a biopharmaceutical company that develops and commercializes novel therapies for the treatment of cancer and immune mediated diseases.. Read morePharmacyclics
is a biopharmaceutical company that develops and commercializes novel therapies for the treatment of cancer and immune mediated diseases.. Read more
News
Jan 22, 2026
Westernindiajournal
Pharmacyclics: Marginal Zone Lymphoma Market: High-Growth Opportunities for Investors to 2034 - DelveInsight | Gilead Sciences, AstraZeneca, Nordic Nanovector, Christian Buske, AbbVie, Pharmacyclics LLC, Hutchison
Oct 21, 2025
Montpelierjournal
Pharmacyclics: Graft-Versus Host Disease Market Expected to Gain Momentum Through 2034, According to DelveInsight | CSL Behring, Equillium, Biocon, MaaT Pharma, Regimmune, Jazz Pharma, Pharmacyclics LLC., Novartis
Oct 01, 2025
Trentonchronicle
Pharmacyclics: Marginal Zone Lymphoma Market Growth Projections 2024-2034: DelveInsight Analysis | Gilead Sciences, AstraZeneca, Nordic Nanovector, Christian Buske, AbbVie, Pharmacyclics LLC, Hutchison Medipharma
May 20, 2025
Northernindiaherald
Pharmacyclics: Marginal Zone Lymphoma Market Growth to Accelerate in Forecast Period (2024-2034), DelveInsight Analyzes | Gilead Sciences, AstraZeneca, Nordic Nanovector, Christian Buske, AbbVie, Pharmacyclics LLC
May 06, 2025
Koreanewswire
Pharmacyclics: U.S. Patent and Trademark Office Invalidates Pharmacyclics Patent Asserted Against BeiGene
Dec 17, 2024
Jamshedpurreporter
Pharmacyclics: Graft-Versus-Host Disease Market on Track for Major Expansion by 2034, According to DelveInsight | CSL Behring, Equillium, Biocon, MaaT Pharma, Regimmune, Jazz Pharma, Pharmacyclics, Novartis
Jun 27, 2023
Trendradars
Pharmacyclics: AbbVie's Pharmacyclics files patent suit against BeiGene over BTK rival Brukinsa
Jun 16, 2023
Endpoints News
Pharmacyclics: AbbVie's Pharmacyclics files patent suit against BeiGene over BTK rival Brukinsa
Jun 15, 2023
Southernsportstoday
Pharmacyclics: BeiGene to Vigorously Defend Patent Infringement Allegations by Pharmacyclics
Mar 29, 2023
The Business Journals
Pharmacyclics: After diabetes drug delivers good data, Peninsula company seeks $125M
Pharmacyclics Competitors
1
2
3
4
5
6
7
8
9
10